Glutamine-addicted ccRCC tumors deprive the tumor microenvironment of glutamine
Human Safety Data Is Minimal A tiny 2025 pilot study testing IV BPC-157 up to 20 mg in 2 healthy adults found it well tolerated with no adverse events and no biomarker changes, but 2 subjects provide essentially zero statistical power
A comprehensive review of 13 studies involving gout patients revealed that long-term use of a vitamin C supplement significantly lowered blood uric acid levels compared to a placebo
The IV delivery ensures maximum absorption and faster results compared to other methods
GHK-Cu provides collagen synthesis, extracellular matrix rebuilding, and systemic gene modulation, while BPC-157 drives angiogenesis, gut healing, and deep tissue repair
Store BPC-157 properly, stay consistent, and pair it with a healthy lifestyle for optimal results